Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
2.850
+0.060 (2.15%)
At close: May 12, 2025, 4:00 PM
2.640
-0.210 (-7.37%)
After-hours: May 12, 2025, 7:59 PM EDT
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $283.06 million as of May 12, 2025. Its market cap has decreased by -19.82% in one year.
Market Cap
283.06M
Enterprise Value
253.54M
1-Year Change
-19.82%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has decreased from $393.23M to $283.06M, a decrease of -28.01%. That is a compound annual growth rate of -4.72%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |